{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T01:51:30Z","timestamp":1785462690273,"version":"3.56.0"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T00:00:00Z","timestamp":1651449600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Surg."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>The treatment of pediatric optic pathway gliomas (OPG) is challenging. At present, most centers provide individualized treatment to maximize progression free survival (PFS) and minimize morbidity. We aim to report our experience in the management of pediatric OPG, and investigate factors associated with an increased duration of remission after treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This is a single-institution study approved by the hospital ethics board. A retrospective review of consecutive OPGs managed from 2000 to 2020 was performed. Patients were divided into those managed with monomodality treatment (MT) and those who received combined therapy (CT). MT included various forms of surgery, chemotherapy and radiotherapy given alone, while CT involves a combination of surgery and adjuvant chemotherapy and\/or radiotherapy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Twenty-two patients were selected for this study. They had 40 treatment cycles; and a total follow up duration of 194.8 patient-years. Most of them were male (63.6%) and presented with visual deficits (72.7%). The mean age at initial presentation was 65 months and majority (86.4%) had their tumors arising directly from the optic chiasm, with 77.3% with hypothalamic extension. One patient had Neurofibromatosis type I (4.5%). The most common histological diagnosis was pilocytic astrocytoma (90.9%), followed by pilomyxoid astrocytoma (9.1%). The 5- and 10- year PFS were 46.2% and 36.4% respectively, while the 5- and 10-year OS were both 100%. When accounting for treatment type, there were 24 treatment cycles with MT (60.0%) and 16 CT (40.0%). After adjustment, treatments with MT were shown to have a shorter mean duration of remission (MT: 45\u2009\u00b1\u200949, CT: 84\u2009\u00b1\u200979 months; <jats:italic>p<\/jats:italic>\u2009=\u20090.007). Cox regression curve plotted after adjusting for patient\u2019s age at treatment demonstrated a significantly longer PFS in the CT group (<jats:italic>p<\/jats:italic>\u2009=\u20090.037).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Our results suggest a significant survival benefit of CT over MT for affected patients due to the prolonged the duration of disease remission, for both primary and subsequent treatments. Nonetheless, we acknowledge that our study reflects the outcomes of treatment strategies that have evolved over time. We emphasize the need for collective efforts from a dedicated multidisciplinary team and international collaborations for better disease understanding.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fsurg.2022.827675","type":"journal-article","created":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T06:11:10Z","timestamp":1651471870000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Monomodality versus Combined Therapy in Optic Pathway Gliomas\u201420-Year Experience from a Singapore Children\u2019s Hospital"],"prefix":"10.3389","volume":"9","author":[{"given":"Jia Xu","family":"Lim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrica E.K.","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee Ping","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan Tew","family":"Seow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth T.E.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ru Xin","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen Shen","family":"Looi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.Y.","family":"Low","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon Y.Y.","family":"Low","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,5,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"E3","DOI":"10.3171\/foc.2007.23.5.4","article-title":"Syndromic and sporadic pediatric optic pathway gliomas: review of clinical and histopathological differences and treatment implications","volume":"23","author":"Shamji","year":"2007","journal-title":"Neurosurg Focus"},{"key":"B2","doi-asserted-by":"publisher","first-page":"143","DOI":"10.2217\/cns.12.47","article-title":"Optic pathway gliomas: a review","volume":"2","author":"Fried","year":"2013","journal-title":"CNS Oncol"},{"key":"B3","volume-title":"WHO classification of tumours of the central nervous system","author":"Louis","year":"2016"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2176\/nmc.ra.2017-0081","article-title":"Pediatric optic pathway\/hypothalamic glioma","volume":"58","author":"Aihara","year":"2018","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1007\/s00381-020-04697-1","article-title":"Neurofibromatosis 1-associated optic pathway gliomas","volume":"36","author":"Shofty","year":"2020","journal-title":"Childs Nerv Syst"},{"key":"B6","doi-asserted-by":"publisher","first-page":"166","DOI":"10.3171\/2019.2.PEDS18529","article-title":"Long-term clinical and visual outcomes after surgical resection of pediatric pilocytic\/pilomyxoid optic pathway gliomas","volume":"24","author":"Hidalgo","year":"2019","journal-title":"J Neurosurg Pediatr"},{"key":"B7","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1001\/archopht.119.4.516","article-title":"Spontaneous regression of optic gliomas: thirteen cases documented by serial neuroimaging","volume":"119","author":"Parsa","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1002\/pbc.22198","article-title":"Natural history and outcome of optic pathway gliomas in children","volume":"53","author":"Nicolin","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"B9","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s004010051161","article-title":"Gliomas of the optic nerve: histological, immunohistochemical (MIB-1 and p53), and MRI analysis","volume":"99","author":"Cummings","year":"2000","journal-title":"Acta Neuropathol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/s0360-3016(02)04512-1","article-title":"Optic gliomas: a retrospective analysis of 50 cases","volume":"56","author":"Khafaga","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1200\/JCO.2011.36.6054","article-title":"Randomized study of two chemotherapy regimens for treatment of low-grade glioma in young children: a report from the Children\u2019s Oncology Group","volume":"30","author":"Ater","year":"2012","journal-title":"J Clin Oncol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.wneu.2016.02.042","article-title":"Treatment and Outcome in 65 Children with Optic Pathway Gliomas","volume":"89","author":"El Beltagy","year":"2016","journal-title":"World Neurosurg"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.wneu.2017.09.144","article-title":"Analysis of survival prognosis for children with symptomatic optic pathway gliomas who received surgery","volume":"109","author":"Liu","year":"2018","journal-title":"World Neurosurg"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3171\/2013.8.PEDS12546","article-title":"The role of surgery in optic pathway\/hypothalamic gliomas in children","volume":"13","author":"Goodden","year":"2014","journal-title":"J Neurosurg Pediatr"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1016\/j.clinph.2020.05.007","article-title":"Intraoperative visual evoked potential monitoring for optic pathway glioma in an infant: A case description","volume":"131","author":"Qiu","year":"2020","journal-title":"Clin Neurophysiol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1001\/archneurpsyc.1958.02340060003001","article-title":"Gliomas of the optic nerves","volume":"79","author":"Dodge","year":"1958","journal-title":"AMA Arch Neurol Psychiatry"},{"key":"B17","doi-asserted-by":"publisher","first-page":"3691","DOI":"10.1200\/JCO.2008.21.2738","article-title":"Late effects of conformal radiation therapy for pediatric patients with low-grade glioma: prospective evaluation of cognitive, endocrine, and hearing deficits","volume":"27","author":"Merchant","year":"2009","journal-title":"J Clin Oncol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s11940-014-0333-2","article-title":"Treatment options for optic pathway gliomas","volume":"17","author":"Thomas","year":"2015","journal-title":"Curr Treat Options Neurol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1093\/neuonc\/now282","article-title":"A phase I trial of the MEK inhibitor selumetinib (AZD6244) in pediatric patients with recurrent or refractory low-grade glioma: a Pediatric Brain Tumor Consortium (PBTC) study","volume":"19","author":"Banerjee","year":"2017","journal-title":"Neuro Oncol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s00381-018-3994-4","article-title":"Endoscopic transnasal resection of optic pathway pilocytic astrocytoma","volume":"35","author":"Bin Abdulqader","year":"2019","journal-title":"Childs Nerv Syst"},{"key":"B21","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1159\/000028680","article-title":"Potential prognostic factors of relapse-free survival in childhood optic pathway glioma: a multivariate analysis","volume":"29","author":"Chan","year":"1998","journal-title":"Pediatr Neurosurg"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1016\/j.ejca.2006.02.022","article-title":"Prognostic factors for progression of childhood optic pathway glioma: a systematic review","volume":"42","author":"Opocher","year":"2006","journal-title":"Eur J Cancer"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1038\/modpathol.2008.88","article-title":"Clinicopathological features and global genomic copy number alterations of pilomyxoid astrocytoma in the hypothalamus\/optic pathway: comparative analysis with pilocytic astrocytoma using array-based comparative genomic hybridization","volume":"21","author":"Jeon","year":"2008","journal-title":"Mod Pathol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1146\/annurev-pathol-020712-164009","article-title":"Pathological and molecular advances in pediatric low-grade astrocytoma","volume":"8","author":"Rodriguez","year":"2013","journal-title":"Annu Rev Pathol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"4190","DOI":"10.1002\/cncr.29649","article-title":"Long-term visual outcome after chemotherapy for optic pathway glioma in children: Site and age are strongly predictive","volume":"121","author":"Dodgshun","year":"2015","journal-title":"Cancer"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e0127676","DOI":"10.1371\/journal.pone.0127676","article-title":"Mortality in children with optic pathway glioma treated with up-front BB-SFOP chemotherapy","volume":"10","author":"Rakotonjanahary","year":"2015","journal-title":"PLoS One"},{"key":"B27","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/0090-3019(87)90309-0","article-title":"Hypothalamic glioma","volume":"28","author":"Gillett","year":"1987","journal-title":"Surg Neurol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"661","DOI":"10.3171\/jns.1990.73.5.0661","article-title":"Surgical management of exophytic chiasmatic-hypothalamic tumors of childhood","volume":"73","author":"Wisoff","year":"1990","journal-title":"J Neurosurg"},{"key":"B29","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1002\/pbc.20655","article-title":"Optic pathway gliomas","volume":"46","author":"Jahraus","year":"2006","journal-title":"Pediatr Blood Cancer"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1586\/14737140.7.11.1591","article-title":"Management of optic-hypothalamic gliomas in children: still a challenging problem","volume":"7","author":"Massimi","year":"2007","journal-title":"Expert Rev Anticancer Ther"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1007\/s00381-021-05060-8","article-title":"Neurosurgical experience of managing optic pathway gliomas","volume":"37","author":"Hill","year":"2021","journal-title":"Childs Nerv Syst"}],"container-title":["Frontiers in Surgery"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fsurg.2022.827675\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T06:11:14Z","timestamp":1651471874000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fsurg.2022.827675\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,2]]},"references-count":31,"alternative-id":["10.3389\/fsurg.2022.827675"],"URL":"https:\/\/doi.org\/10.3389\/fsurg.2022.827675","relation":{},"ISSN":["2296-875X"],"issn-type":[{"value":"2296-875X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,2]]},"article-number":"827675"}}